1 |
Chen Y, Zhang H, Liu E, Xu C, Zhang Y. Homocysteine regulates endothelin type B receptors in vascular smooth muscle cells. Vascular Pharmacology 2016;87:100-9. [DOI: 10.1016/j.vph.2016.08.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
2 |
Wang YY, Yang YX, Zhe H, He ZX, Zhou SF. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties. Drug Des Devel Ther 2014;8:2075-88. [PMID: 25364233 DOI: 10.2147/DDDT.S68872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
|
3 |
Sun X, Zhang H, Qin Q, Zhang X, Hou Y, Chen D, Su X, Jia M, Chen Y. Inhibitors of the MAPK/ NF-κB pathway attenuate the upregulation of the ETB receptor mediated by high glucose in vascular smooth muscle cells. Peptides 2021;:170732. [PMID: 34971676 DOI: 10.1016/j.peptides.2021.170732] [Reference Citation Analysis]
|
4 |
Zhang Y, Mi M, Xie YH, Wang SW, Edvinsson L, Xu CB. Downregulation of Thromboxane A2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery. Adv Pharmacol Sci 2017;2017:6507048. [PMID: 28775740 DOI: 10.1155/2017/6507048] [Reference Citation Analysis]
|
5 |
Al-Sawaf O, Clarner T, Fragoulis A, Kan YW, Pufe T, Streetz K, Wruck CJ. Nrf2 in health and disease: current and future clinical implications. Clin Sci (Lond) 2015;129:989-99. [PMID: 26386022 DOI: 10.1042/CS20150436] [Cited by in Crossref: 79] [Cited by in F6Publishing: 40] [Article Influence: 11.3] [Reference Citation Analysis]
|